What You Should Know: - Primary care is continuing to decentralize with more decisions made outside of primary care offices, according to a recent report by Wolters Kluwer. - The Pharmacy Next: Health Consumer Medication Trends survey explores consumer sentiment amid this shift, and offers insight into what safeguards are needed to address their top concerns around medication-related care. Research-Driven Prospects Regarding Changes in American Primary Healthcare The Pharmacy Next:
Read More
Pharmacogenomics: The Key to Unlocking the Future of Personalized Healthcare
Pharmacogenomics—the study of genetic influences on an individual's response to therapeutic medications—is an area of personalized medicine that is gaining momentum. Although pharmacogenomics has been around for a while, providers, health plans, pharmacists and legislators are developing a greater appreciation for its potential benefits and applications. How Can Pharmacogenomics Improve Outcomes? By considering a person’s DNA in treatment options, providers can determine how an
Read More
Invitae Launches Genomics-Forward Digital Health Platform
What You Should Know: - Invitae launches a seamless digital platform to enhance patient and provider experiences and further bring genetics to mainstream medicine. - Offering seamless integrations with EHR solutions, Invitae Digital Health will provide healthcare systems with a customizable suite of tools in a single, intuitive platform. Invitae, a San Francisco, CA, based medical genetics company, announced the launch of Invitae Digital Health—a connected
Read More
Why Mainstream Precision Medicine Hinges on Healthcare HPC Storage
The healthcare industry is experiencing a data deluge, and it shows no sign of slowing down. In 2020, estimates reported that healthcare data comprised a staggering 30% of the world’s total data volume; projections for 2025 bump that number up to 36%, a growth rate outpacing every other industry. This is promising news for precision medicine, the data-driven healthcare initiative that promotes the right treatment for the right patient at the right time. Precision (or personalized)
Read More
Report: Precision Medicine Is Impossible Without AI and Machine Learning
Artificial intelligence (AI) and machine learning are driving a great deal of the healthcare innovation in precision medicine, according to a new Chilmark Research report. The report reveals achieving the full potential of precision medicine is impossible to realize without applying AI and machine learning. Specifically, leveraging advanced machine learning and deep learning technology can rapidly analyze large datasets that outperform clinicians and researchers. Precision Medicine: Making
Read More
Mount Sinai Launches Center for Artificial Intelligence and Human Health
The Icahn School of Medicine at Mount Sinai today announced the launch of a new center dedicated to advancing the delivery of health care through research, development, and implementation of innovative artificial intelligence tools and technologies. The Hamilton and Amabel James Center for Artificial Intelligence and Human Health in Manhattan to combine artificial intelligence with data science and genomics in a standalone site. The building will enable researchers to enhance their
Read More
Mount Sinai Appoints Andrew Kasarskis As First-Ever Chief Data Officer
Mount Sinai has appointed Andrew Kasarskis, Ph.D., an internationally recognized expert in biomedical data as the health system’s first-ever Executive Vice President and Chief Data Officer (CDO). In this new role, Dr. Kasarskis will facilitate the accessibility and sharing of clinical, financial, and administrative data, and open application development, all in support of better patient care, decision-making, and healthcare innovation. Accelerating Data-Driven Discovery and Patient
Read More
Precision Medicine Startup 2bPrecise Brings Pharmacogenomics to the Point of Care
2bPrecise., an EHR-agnostic, cloud-based precision medicine platform, recently announced its new pharmacogenomics (PGx) solution that takes pharmacogenetic information and makes it actionable for physicians. The solution pushes live, real-time PGx content directly into the clinical setting so clinicians can more precisely diagnose and treat their patients.2bPrecise has partnered with Translational Software, Inc. (TSI), a leader in the intelligent use of genomic data for clinical decision
Read More
